Overview
What is Society For Immunotherapy Of Cancer Inc?
The Society for Immunotherapy of Cancer Inc, based in Milwaukee, Wisconsin, is a nonprofit organization dedicated to enhancing cancer patient outcomes by advancing the field of cancer immunology and immunotherapy. Through their interactions and integrations, innovations, translations, and leadership, they strive to make cancer immunotherapy a standard of care and ultimately, a reality for patients worldwide. The organization, with a significant presence, held the 37th annual meeting and pre-conference programs (SITC 2022), where experts shared cutting-edge research, fostered discussions, and provided networking opportunities. Their mission encompasses improving cancer patient outcomes and scientific advancements in immunotherapy, with a vision of transforming the concept of "cure" into a tangible reality.
Official website here: www.sitcancer.org
Is Society For Immunotherapy Of Cancer Inc legitimate?
Society For Immunotherapy Of Cancer Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Society For Immunotherapy Of Cancer Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $18,000
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
Official website here: www.sitcancer.org
What is the mission statement of Society For Immunotherapy Of Cancer Inc?
The Society for Immunotherapy of Cancer Inc is dedicated to enhancing cancer patient outcomes by progressing the field of cancer immunology and immunotherapy. This organization upholds key values, including interaction and integration, innovation, translation, and leadership, to advance research and bring cancer immunotherapy closer to becoming a standard of care. The Society aims to make the prospect of a cure for cancer a reality for patients worldwide.
Official website here: www.sitcancer.org
Who is the CEO of Society For Immunotherapy Of Cancer Inc?
Leisha Emens Md Phd is the Vice President of Society For Immunotherapy Of Cancer Inc.
Official website here: www.sitcancer.org
What is the revenue of Society For Immunotherapy Of Cancer Inc?
Society For Immunotherapy Of Cancer Inc's revenue in 2022 was $17,242,766.
Official website here: www.sitcancer.org
Who are the executives of Society For Immunotherapy Of Cancer Inc and what are their salaries?
- Christian Capitini Md (Director)
- Leisha Emens Md Phd (Vice President) [Trustee/Director]
- Jennifer Wargo Md Mmsc (Director)
- Ann Silk Md Ms (Director)
- Jennifer Guerriero Phd (Director)
- Patrick Hwu Md (President) [Trustee/Director]
- Jedd Wolchok Md Phd (Secr/Treasurer) [Trustee/Director]
- Mario Sznol Md (Imm. Past Pres.) [Trustee/Director]
- Alessandra Cesano Md Phd (Director)
- Tanja De Gruijl Phd (Director)
- Stefani Spranger Phd (Director)
- Adekunle Odunsi Md Phd Frcog Faco (Director)
- Julie Brahmer Md (Director)
Official website here: www.sitcancer.org
Where can I find the form 990 for Society For Immunotherapy Of Cancer Inc?
The Society For Immunotherapy Of Cancer Inc’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.sitcancer.org
Learn more at the official website: www.sitcancer.org
Mission Statement of Society For Immunotherapy Of Cancer Inc
The Society for Immunotherapy of Cancer Inc, or SITC, is a nonprofit organization dedicated to enhancing cancer patient outcomes by driving the advancement of cancer immunology and immunotherapy. With a strong focus on interaction and integration, innovation, translation, and leadership in the field, SITC strives to bring cancer immunotherapy to the forefront as a standard of care and make the word "cure" a reality for cancer patients worldwide.
In essence, SITC is committed to pushing the boundaries of scientific discovery and its practical application to revolutionize cancer treatment. Through its core values, the organization fosters collaboration and partnerships, nurtures groundbreaking research, and champions the translation of immunotherapy breakthroughs into clinical practice. By leading the way in the field, SITC remains at the helm of the fight against cancer, continually working towards a world where the promise of a cure becomes a reality for all patients.
In the pursuit of its mission, SITC brings together some of the most brilliant minds in the field of cancer research and immunotherapy, fostering a vibrant and dynamic community of scientists, clinicians, and industry professionals. With a shared vision for a future where cancer is no longer a death sentence, SITC empowers its members to collaborate and innovate, united in their quest to transform cancer care and improve the lives of countless patients.
Impact
This information is meant to be a general summary of Society For Immunotherapy Of Cancer Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
Society For Immunotherapy Of Cancer Inc aims to improve cancer patient outcomes by advancing the science, development, and application of cancer immunology and immunotherapy. Through their core values of interaction/integration, innovation, translation, and leadership in the field, they strive to make cancer immunotherapy a standard of care and work towards turning the word "cure" into a reality for cancer patients worldwide. Their recent event, the 37th Annual Meeting & Pre-Conference Programs, provided a multidisciplinary educational and interactive environment focused on incorporating strategies based on basic and applied cancer immunotherapy to improve outcomes for current and future cancer patients. This event showcased cutting-edge research presentations, oral and poster abstract presentations, and networking opportunities to facilitate important discussions and collaborations in the field. The Society's efforts in medical research contribute significantly to the advancement of cancer immunotherapy and bring hope for better treatment options and outcomes for cancer patients.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
ANNUAL MEETING
Revenue
$9,007,636
MEMBERSHIP DUES & ASSESSMENTS
Revenue
$1,490,145
PUBLISHER REVENUE
Revenue
$500,139
WORKSHOP
Revenue
$405,610
PRIMER
Revenue
$374,138
Organization Details
Founding Year
1986
Phone
(414) 271-2456
Principal Officer
Leisha Emens Md Phd
Main Address
555 E WELLS STREET 1100, MILWAUKEE, WI, 53202
Website
www.sitcancer.org
NTEE Category
Code: H30 - Medical research
If you are a representative of Society For Immunotherapy Of Cancer Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.